Terminal Vascular Intervention - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243139

Publication Date:

October 24, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Terminal vascular intervention refers to the use of 1-2 mm thick puncture needles to penetrate the shallow arteries and veins of the human body to enter the human vascular system. With the knowledge of vascular anatomy, the doctor will guide the catheter to the lesion under the guidance of the angiography machine. At this location, a method of injecting a contrast agent through a catheter, displaying the condition of the diseased blood vessel, and treating the disease in the blood vessel. Common body surface puncture points include femoral arteriovenous, radial arteries, subclavian arteriovenous, jugular vein arteriovenous, and so on.
The global market for Terminal Vascular Intervention was estimated to be worth US$ 2439 million in 2023 and is forecast to a readjusted size of US$ 4316.9 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030
The global market for terminal vascular intervention encompasses a range of medical devices, equipment, and procedures aimed at diagnosing and treating vascular conditions through minimally invasive techniques. This market is strongly influenced by factors such as technological advancements, increasing prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, and expanding healthcare infrastructure in both developed and developing regions.
Key components and segments within the global terminal vascular intervention market include:
Catheters and Guidewires: These are essential tools used for navigating the vascular system and accessing specific areas of interest for diagnostic and therapeutic purposes.
Vascular Stents: These devices are employed to support narrowed or weakened blood vessels, often used in conjunction with angioplasty to restore blood flow.
Angioplasty Balloons: These balloons are used to widen narrowed or obstructed arteries, typically in the context of treating conditions such as atherosclerosis.
Embolization Devices: These devices are utilized to block abnormal blood vessels or control bleeding within the vascular system.
Atherectomy Devices: These tools are employed to remove plaque from blood vessels, contributing to the restoration of healthy blood flow.
Diagnostic Imaging Systems: Various imaging modalities, including angiography machines and intravascular ultrasound, play a critical role in guiding interventional procedures and assessing vascular conditions.
The global market for terminal vascular intervention is supported by a wide array of medical device manufacturers and healthcare providers who are dedicated to advancing the field through research, development, and clinical application. Additionally, the market is shaped by regulatory frameworks, reimbursement mechanisms, and ongoing efforts to improve patient outcomes and safety in vascular interventions.
Several factors drive the growth of the global terminal vascular intervention market, including a rising prevalence of vascular diseases such as peripheral artery disease and coronary artery disease, an increasing geriatric population, technological innovations in interventional cardiology and radiology, and the expansion of healthcare infrastructure in emerging economies.
As the demand for minimally invasive vascular procedures continues to rise, the global market for terminal vascular intervention is poised to experience ongoing advancements, market expansions, and strategic alliances aimed at addressing the evolving needs of patients and healthcare providers. Furthermore, the integration of cutting-edge technologies and the development of advanced materials are expected to further enhance the efficacy and safety of terminal vascular intervention procedures.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Terminal Vascular Intervention, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Terminal Vascular Intervention by region & country, by Type, and by Application.
The Terminal Vascular Intervention market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terminal Vascular Intervention.
Market Segmentation
By Company
Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex
Segment by Type:
Catheter Guide
Rotary Cutting Equipment
Embolization Equipment
Thrombectomy Equipment
IVC Filter
Other
Segment by Application
Vascular Disease
Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Terminal Vascular Intervention manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Terminal Vascular Intervention in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Terminal Vascular Intervention in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Terminal Vascular Intervention Product Introduction
1.2 Global Terminal Vascular Intervention Market Size Forecast
1.3 Terminal Vascular Intervention Market Trends & Drivers
1.3.1 Terminal Vascular Intervention Industry Trends
1.3.2 Terminal Vascular Intervention Market Drivers & Opportunity
1.3.3 Terminal Vascular Intervention Market Challenges
1.3.4 Terminal Vascular Intervention Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Terminal Vascular Intervention Players Revenue Ranking (2023)
2.2 Global Terminal Vascular Intervention Revenue by Company (2019-2024)
2.3 Key Companies Terminal Vascular Intervention Manufacturing Base Distribution and Headquarters
2.4 Key Companies Terminal Vascular Intervention Product Offered
2.5 Key Companies Time to Begin Mass Production of Terminal Vascular Intervention
2.6 Terminal Vascular Intervention Market Competitive Analysis
2.6.1 Terminal Vascular Intervention Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Terminal Vascular Intervention Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terminal Vascular Intervention as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Catheter Guide
3.1.2 Rotary Cutting Equipment
3.1.3 Embolization Equipment
3.1.4 Thrombectomy Equipment
3.1.5 IVC Filter
3.1.6 Other
3.2 Global Terminal Vascular Intervention Sales Value by Type
3.2.1 Global Terminal Vascular Intervention Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Terminal Vascular Intervention Sales Value, by Type (2019-2030)
3.2.3 Global Terminal Vascular Intervention Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Vascular Disease
4.1.2 Cancer
4.1.3 Other
4.2 Global Terminal Vascular Intervention Sales Value by Application
4.2.1 Global Terminal Vascular Intervention Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Terminal Vascular Intervention Sales Value, by Application (2019-2030)
4.2.3 Global Terminal Vascular Intervention Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Terminal Vascular Intervention Sales Value by Region
5.1.1 Global Terminal Vascular Intervention Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Terminal Vascular Intervention Sales Value by Region (2019-2024)
5.1.3 Global Terminal Vascular Intervention Sales Value by Region (2025-2030)
5.1.4 Global Terminal Vascular Intervention Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Terminal Vascular Intervention Sales Value, 2019-2030
5.2.2 North America Terminal Vascular Intervention Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Terminal Vascular Intervention Sales Value, 2019-2030
5.3.2 Europe Terminal Vascular Intervention Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Terminal Vascular Intervention Sales Value, 2019-2030
5.4.2 Asia Pacific Terminal Vascular Intervention Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Terminal Vascular Intervention Sales Value, 2019-2030
5.5.2 South America Terminal Vascular Intervention Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Terminal Vascular Intervention Sales Value, 2019-2030
5.6.2 Middle East & Africa Terminal Vascular Intervention Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Terminal Vascular Intervention Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Terminal Vascular Intervention Sales Value
6.3 United States
6.3.1 United States Terminal Vascular Intervention Sales Value, 2019-2030
6.3.2 United States Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Terminal Vascular Intervention Sales Value, 2019-2030
6.4.2 Europe Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Terminal Vascular Intervention Sales Value, 2019-2030
6.5.2 China Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.5.3 China Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Terminal Vascular Intervention Sales Value, 2019-2030
6.6.2 Japan Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Terminal Vascular Intervention Sales Value, 2019-2030
6.7.2 South Korea Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Terminal Vascular Intervention Sales Value, 2019-2030
6.8.2 Southeast Asia Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Terminal Vascular Intervention Sales Value, 2019-2030
6.9.2 India Terminal Vascular Intervention Sales Value by Type (%), 2023 VS 2030
6.9.3 India Terminal Vascular Intervention Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Terminal Vascular Intervention Products, Services and Solutions
7.1.4 Abbott Laboratories Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 AgioDynamics Inc.
7.2.1 AgioDynamics Inc. Profile
7.2.2 AgioDynamics Inc. Main Business
7.2.3 AgioDynamics Inc. Terminal Vascular Intervention Products, Services and Solutions
7.2.4 AgioDynamics Inc. Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.2.5 AgioDynamics Inc. Recent Developments
7.3 B. Braun
7.3.1 B. Braun Profile
7.3.2 B. Braun Main Business
7.3.3 B. Braun Terminal Vascular Intervention Products, Services and Solutions
7.3.4 B. Braun Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.3.5 Cardinal Health Recent Developments
7.4 Cardinal Health
7.4.1 Cardinal Health Profile
7.4.2 Cardinal Health Main Business
7.4.3 Cardinal Health Terminal Vascular Intervention Products, Services and Solutions
7.4.4 Cardinal Health Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.4.5 Cardinal Health Recent Developments
7.5 Biotronik
7.5.1 Biotronik Profile
7.5.2 Biotronik Main Business
7.5.3 Biotronik Terminal Vascular Intervention Products, Services and Solutions
7.5.4 Biotronik Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.5.5 Biotronik Recent Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Profile
7.6.2 Boston Scientific Corporation Main Business
7.6.3 Boston Scientific Corporation Terminal Vascular Intervention Products, Services and Solutions
7.6.4 Boston Scientific Corporation Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.6.5 Boston Scientific Corporation Recent Developments
7.7 Cook Group
7.7.1 Cook Group Profile
7.7.2 Cook Group Main Business
7.7.3 Cook Group Terminal Vascular Intervention Products, Services and Solutions
7.7.4 Cook Group Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.7.5 Cook Group Recent Developments
7.8 C.R. Bard
7.8.1 C.R. Bard Profile
7.8.2 C.R. Bard Main Business
7.8.3 C.R. Bard Terminal Vascular Intervention Products, Services and Solutions
7.8.4 C.R. Bard Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.8.5 C.R. Bard Recent Developments
7.9 Depuy Synthesis
7.9.1 Depuy Synthesis Profile
7.9.2 Depuy Synthesis Main Business
7.9.3 Depuy Synthesis Terminal Vascular Intervention Products, Services and Solutions
7.9.4 Depuy Synthesis Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.9.5 Depuy Synthesis Recent Developments
7.10 Medtronic
7.10.1 Medtronic Profile
7.10.2 Medtronic Main Business
7.10.3 Medtronic Terminal Vascular Intervention Products, Services and Solutions
7.10.4 Medtronic Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.10.5 Medtronic Recent Developments
7.11 Meril Life Sciences India Pvt Ltd
7.11.1 Meril Life Sciences India Pvt Ltd Profile
7.11.2 Meril Life Sciences India Pvt Ltd Main Business
7.11.3 Meril Life Sciences India Pvt Ltd Terminal Vascular Intervention Products, Services and Solutions
7.11.4 Meril Life Sciences India Pvt Ltd Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.11.5 Meril Life Sciences India Pvt Ltd Recent Developments
7.12 Teleflex
7.12.1 Teleflex Profile
7.12.2 Teleflex Main Business
7.12.3 Teleflex Terminal Vascular Intervention Products, Services and Solutions
7.12.4 Teleflex Terminal Vascular Intervention Revenue (US$ Million) & (2019-2024)
7.12.5 Teleflex Recent Developments
8 Industry Chain Analysis
8.1 Terminal Vascular Intervention Industrial Chain
8.2 Terminal Vascular Intervention Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Terminal Vascular Intervention Sales Model
8.5.2 Sales Channel
8.5.3 Terminal Vascular Intervention Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂